PlainRecalls
FDA Drug Moderate Class II Terminated

Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 41616-638-68, UPC 3 41616 63868 4.

Reported: March 9, 2016 Initiated: February 11, 2016 #D-0735-2016

Product Description

Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 41616-638-68, UPC 3 41616 63868 4.

Reason for Recall

Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.

Details

Recalling Firm
Sun Pharma Global Fze
Units Affected
381,120 cartons
Distribution
Nationwide and Puerto Rico
Location
Sharm, N/A

Frequently Asked Questions

What product was recalled?
Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 41616-638-68, UPC 3 41616 63868 4.. Recalled by Sun Pharma Global Fze. Units affected: 381,120 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 9, 2016. Severity: Moderate. Recall number: D-0735-2016.